The Use Of Antifungal Drugs Used In Newborn
SELVİ GÜLAŞI, ÜMİT ÇELİK
- Year : 2018
- Vol : 34
- Issue : 1
- Page :
40-50
Invasive candidiasis is responsible for about 10% of nosocomial sepsis and it continues to be
significant cause of serious morbidity and mortality in very low birth weight infants. Alhough
the informations about the antifungal drugs which used for Candida species are increasing,
studies and conclusions about the efficacy and safety are still insufficient. Most of the studies
have focused on the pharmacokinetic and pharmacodynamic evaluations and obtained from
adult patients. However, efectiveness of the therapy can not be same in newborns due to
the different pathophysiology of neonatal candidiasis in newborn, the inferences can not
be considered from adult studies. Until now, amphotericin B deoxycholate, fluconazole and
micafungin seems to be effectivev therapy for the treatment of neonatal invasive candidiasis.
Herein, the medical literature has been scanned and compiled with the latest information
about the use of antifungal agents in newborn.
Cite this Article As :
Gülaşı S, Çelik Ü. Yenidoğanlarda Antifungal İlaç Kullanımı. Selcuk Med J 2018;34(1): 40-50
Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File
Download Citation: BibTeX BibTeX File
Description :
None of the authors, any product mentioned in this article,
does not have a material interest in the device or drug. Research,
not supported by any external organization.
grant full access to the primary data and, if requested by the magazine
they agree to allow the examination of data.
The Use Of Antifungal Drugs Used In Newborn
2018,
Vol.
34
(1)
Received : 01.01.2016,
Accepted : 01.01.2016,
Published Online : 13.08.2018
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;